Finance

Lists
6838:TPE
Formosa Pharmaceuticals Inc
25,10 NT$
0,00%
(0,00) 1D
12 қаз., 13:30:26 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6838...
Open
24,70 NT$
High
25,10 NT$
Low
24,70 NT$
Mkt. cap
3,79 млрд
Avg. vol.
166,84 м.
Volume
114,30 м.
52-wk high
33,30 NT$
52-wk low
22,35 NT$
EPS
-1,26 NT$
No. of employees
10
Open
24,70 NT$
High
25,10 NT$
Low
24,70 NT$
Mkt. cap
3,79 млрд
Avg. vol.
166,84 м.
Volume
114,30 м.
52-wk high
33,30 NT$
52-wk low
22,35 NT$
EPS
-1,26 NT$
No. of employees
10
News stories
From web sources and news partners
About Formosa Pharmaceuticals Inc
CEO-
Employees10
Founded2010
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
911,00 м.
3,23 млн
45,42 млн
3,03 млн
Cost of goods sold
6,11 млн
2,72 млн
5,93 млн
7,67 млн
Cost of revenue
6,11 млн
2,72 млн
5,93 млн
7,67 млн
Research and development expenses
25,25 млн
30,71 млн
40,14 млн
61,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,16 млн
9,18 млн
10,00 млн
9,36 млн
Operating expense
39,41 млн
39,89 млн
50,14 млн
71,05 млн
Total operating expenses
45,52 млн
42,61 млн
56,07 млн
78,72 млн
Operating income
-44,61 млн
-39,38 млн
-10,65 млн
-75,69 млн
Other non operating income
-
-1,19 млн
-
-24,00 мың
EBT including unusual items
-59,29 млн
-48,04 млн
-15,00 млн
-65,38 млн
EBT excluding unusual items
-59,29 млн
-48,04 млн
-15,00 млн
-65,38 млн
Income tax expense
-123,00 м.
-124,00 м.
255,00 м.
2,25 млн
Effective tax rate
0,21%
0,26%
-1,70%
-3,44%
Other operating expenses
-
-
-
-
Net income
-59,19 млн
-47,96 млн
-15,26 млн
-67,63 млн
Net profit margin
-6 497,48%
-1 486,83%
-33,60%
-2 235,06%
Earnings per share
-
-
-
-
Interest and investment income
6,14 млн
6,33 млн
5,56 млн
5,54 млн
Interest expense
-128,00 м.
-130,00 м.
-130,00 м.
-124,00 м.
Net interest expenses
6,01 млн
6,20 млн
5,43 млн
5,41 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,34 млн
-28,03 млн
727,00 м.
-64,19 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары